HOOKIPA Pharma (HOOK)
HOOK
Oncology
BiotechSign Signal Grade
F
Signal Grade
1.8/100 composite signal score
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Insider Buying
0
Publications
100
Clinical Activity
0
Short Interest
10
Pipeline Overview
- Therapeutic Focus
- Oncologysrc
Clinical Trial Activity
0
Clinical Trials
(ClinicalTrials.gov aggregate)
(ClinicalTrials.gov aggregate)
5
PubMed Publications
0
Catalyst Records
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Short Interest
0.00%
Float Shorted
1.0
Days to Cover
LOW
Squeeze Risk
+3.4%
SI Change
STABLE
Trend
11,116
Shares Short
Short interest: ?% of float, squeeze risk: LOW
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors. — J Immunother Cancer 2026 Sep 7 PMID 42705861
- APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial. — JCO Precis Oncol 2026 Aug PMID 42628007
- SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1-High, Locally Advanced, Unresectable or Metastatic Non-Small Cell Lung Cancer. — J Clin Oncol 2026 Sep PMID 42507968
- Immunotherapy for locally advanced head and neck squamous cell carcinoma: A review. — Cancer Treat Rev 2026 Sep PMID 42497818
- Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion. — Cancer 2026 Aug 1 PMID 42487497
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for HOOKIPA Pharma.
Full HOOK Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.